1. PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation
    Abdul K. Siraj et al, 2021, Cancers CrossRef

  2. PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP


    Jinfeng Wang et al, 2020, Cancer Management and Research CrossRef
  3. Immunosensitivity mediated by downregulated AKT1-SKP2 induces anti-PD-1-associated thyroid immune injury
    Yanmeizhi Wu et al, 2023, International Immunopharmacology CrossRef